Why Is United Therapeutics (UTHR) Up 3.8% Since Last Earnings Report?Zacks Investment Research • 12/02/22
Can United Therapeutics (UTHR) Run Higher on Rising Earnings Estimates?Zacks Investment Research • 11/10/22
United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare ConferenceBusiness Wire • 11/01/22
United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram TherapyBusiness Wire • 10/31/22
United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022Business Wire • 10/26/22
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual MeetingBusiness Wire • 10/14/22
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary FibrosisBusiness Wire • 10/11/22
United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit ReportBusiness Wire • 09/12/22
Why Is United Therapeutics (UTHR) Up 2.1% Since Last Earnings Report?Zacks Investment Research • 09/02/22
United Therapeutics to Feature Clinical Data at the European Society of Cardiology Congress 2022 and the European Respiratory Society International Congress 2022Business Wire • 08/24/22
United Therapeutics Corporation (UTHR) CEO Dr. Martine Rothblatt on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
United Therapeutics (UTHR) Q2 Earnings Miss Estimates, Revenues UpZacks Investment Research • 08/03/22
United Therapeutics Corporation Reports Second Quarter 2022 Financial ResultsBusiness Wire • 08/03/22
United Therapeutics Corporation to Report Second Quarter 2022 Financial Results Before the Market Opens on Wednesday, August 3, 2022Business Wire • 07/27/22